Novatek International is pleased to announce that SANARIA has chosen key regulatory compliant software solutions from our Product Suite for use at their Rockville, MD USA manufacturing site: Nova-QMS, Nova-Stability, and Nova-EM.
SANARIA’s strategic decision to utilize the building block like components of Novatek’s Product suite reinforces our mandate for organizations in the life sciences industry to build their solution, with the flexibility to grow at their needs and implement at their pace.
We are pleased to welcome SANARIA to our family of clientele and look forward to supporting their Quality and Data needs for years to come.
Sanaria is a biotechnology company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Sanaria’s vaccine is based on an approach to immunization that has already proven highly protective in humans.